Archivio delibere
Seduta del 01/12/2023
Delibera del 01 Dicembre, n. 1137 [file.pdf]
Autorizzazione allo studio clinico dal titolo “Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy: an Observational Study by the GIMEMA WP on Chronic Lymphoproliferative Disorders and by the FIL” – RSO ID319 CLL2423 NCT05803395
Autorizzazione allo studio clinico dal titolo “Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy: an Observational Study by the GIMEMA WP on Chronic Lymphoproliferative Disorders and by the FIL” – RSO ID319 CLL2423 NCT05803395
Data seduta:01/12/2023
In pubblicazione dal: 01/12/2023-al: 15/12/2023
In pubblicazione dal: 01/12/2023-al: 15/12/2023